---
schema_version: "secwatch.filing_event.v1"
accession: "0001097149-26-000033"
form_type: "8-K"
ticker: "ALGN"
cik: "0001097149"
company_name: "ALIGN TECHNOLOGY INC"
filed_at: "2026-04-29T23:59:59+00:00"
generated_at: "2026-05-15T01:33:53.596588+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Align Technology reports Q1 revenue up 6.2% YoY, record Clear Aligner shipments, $200M buyback

## Summary
- Q1 total revenues $1,040.1M, up 6.2% YoY; GAAP diluted EPS $1.57, non-GAAP EPS $2.58.
- Record Clear Aligner shipments of 685.7k cases, up 6.7% YoY, driven by international double-digit growth.
- Q2'26 revenue guidance $1,040M-$1,060M; full-year 2026 guidance reaffirmed (3-4% revenue growth).
- Board approves $200M stock repurchase program to begin May 1, 2026; $800M remains under existing program.
- Gross margin 70.8% GAAP (71.8% non-GAAP); operating margin 13.6% GAAP (21.5% non-GAAP).

## SEC filing metadata
- accession: 0001097149-26-000033
- form_type: 8-K
- ticker: ALGN
- cik: 0001097149
- company_name: ALIGN TECHNOLOGY INC
- filed_at: 2026-04-29T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1097149/000109714926000033/0001097149-26-000033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1097149/000109714926000033/algn-20260429.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001097149-26-000033
- JSON: https://secwatch.observer/filing/0001097149-26-000033.json
- Plain text: https://secwatch.observer/filing/0001097149-26-000033.txt

## Key facts
- Earnings Releases
  ALIGN TECHNOLOGY INC reported first quarter ended March 31, 2026 results: revenue $1,040.1 million, net income $112.8 million, EPS $1.57 per diluted share. Guidance reaffirmed.
  - Period: first quarter ended March 31, 2026
  - Revenue: $1,040.1 million
  - Net income: $112.8 million
  - EPS: $1.57 per diluted share
  - Guidance: reaffirmed
  - Result: reported results
  source text: respectively Q1’26 Invisalign teen/kid patients increased 4.8% year-over-year and Invisalign adult patients increased 7.8% year-over-year • Q1'26 total revenues were $1,040.1 million, down 0.7% sequentially and up 6.2% year-over-year • Q1'26 total revenues were favorably impacted by foreign exchange by approximately $8.7 million sequentially, and favorably
  evidence_url: https://www.sec.gov/Archives/edgar/data/1097149/000109714926000033/0001097149-26-000033-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.